GSK
GSK
817 hedge funds and large institutions have $11.9B invested in GSK in 2020 Q1 according to their latest regulatory filings, with 69 funds opening new positions, 267 increasing their positions, 338 reducing their positions, and 133 closing their positions.
75% more call options, than puts
Call options by funds: $113M | Put options by funds: $64.4M
0.37% more ownership
Funds ownership: 4.62% → 5% (+0.37%)
0% more funds holding in top 10
Funds holding in top 10: 16 → 16 (0)
9% less funds holding
Funds holding: 894 → 817 (-77)
12% less capital invested
Capital invested by funds: $13.5B → $11.9B (-$1.67B)
21% less repeat investments, than reductions
Existing positions increased: 267 | Existing positions reduced: 338
48% less first-time investments, than exits
New positions opened: 69 | Existing positions closed: 133
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Capital International Investors
Los Angeles,
California
|
+$378M |
| 2 |
Royal Bank of Canada
Toronto,
Ontario, Canada
|
+$322M |
| 3 |
Renaissance Technologies
New York
|
+$173M |
| 4 |
Rockefeller Capital Management
New York
|
+$162M |
| 5 |
CCM
Camber Capital Management
Boston,
Massachusetts
|
+$128M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Dodge & Cox
San Francisco,
California
|
-$100M |
| 2 |
Jane Street
New York
|
-$74.6M |
| 3 |
Arrowstreet Capital
Boston,
Massachusetts
|
-$55.9M |
| 4 |
BCIM
Black Creek Investment Management
Toronto,
Ontario, Canada
|
-$45.3M |
| 5 |
JP Morgan Chase
New York
|
-$41.9M |
GSK Hedge Fund Activity: Q1 2020 in Review
817 of the 4,538 institutional investors tracked by Wall St. Rank reported a position in GSK (GSK) for Q1 2020, worth a combined $11.9B — down 12% from $13.5B a quarter earlier.
Sellers outnumbered buyers: 133 funds closed out of GSK and 69 opened new positions — a net loss of 64 holders — while 338 trimmed existing stakes and 267 added.
The largest buyer was Capital International Investors, adding an estimated $378M. The largest seller was Dodge & Cox, cutting an estimated $100M.
- 817 institutional investors held GSK (GSK) as of Q1 2020, down from 894 in Q4 2019.
- Funds reported $11.9B of GSK stock for Q1 2020, down 12% quarter-over-quarter.
- 69 funds opened new GSK positions in Q1 2020 and 133 closed out, a net change of -64 holders.
- The largest GSK buyer in Q1 2020 was Capital International Investors, an estimated $378M added.
- The largest GSK seller in Q1 2020 was Dodge & Cox, an estimated $100M sold.
Based on aggregated 13F filings for Q1 2020.